Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sergey, V Miller"'
Autor:
Konstantin K. Laktionov, Elena V. Artamonova, Tatiana N. Borisova, Valeriy V. Breder, Iurii M. Bychkov, Liubov Iu. Vladimirova, Nikita M. Volkov, Stepan M. Ergnian, Albina S. Zhabina, Pavel V. Kononets, Alexander E. Kuzminov, Evgeny V. Levchenko, Olga A. Malikhova, Dimitr T. Marinov, Sergey V. Miller, Fedor V. Moiseenko, Valeriia V. Mochal’nikova, Sergei N. Novikov, Oleg V. Pikin, Elena V. Reutova, Evgenii O. Rodionov, Dina D. Sakaeva, Ksenia A. Sarantseva, Anna I. Semenova, Aleksei V. Smolin, Vladimir M. Sotnikov, Sergei A. Tuzikov, Igor N. Turkin, Igor E. Tyurin, Vladimir D. Chkhikvadze, Konstantin I. Kolbanov, Marina V. Chernykh, Andrei V. Chernichenko, Aleksandr A. Fedenko, Elena V. Filonenko, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian, Aleksei V. Butenko, Ilmira R. Gil’mutdinova, Irina V. Gridneva, Mikhail A. Eremushkin, Margarita A. Zernova, Boris S. Kasparov, Denis V. Kovlen, Kristina O. Kondrat’eva, Tatiana V. Konchugova, Svetlana B. Korotkova, Anton A. Krutov, Olga A. Obukhova, Gennadii N. Ponomarenko, Tatiana Iu. Semiglazova, Aleksandra M. Stepanova, Marina M. Khulamkhanova
Publikováno v:
Современная онкология, Vol 24, Iss 3, Pp 269-304 (2022)
Externí odkaz:
https://doaj.org/article/a2caace9aacc43548d9d996d4c2021f2
Autor:
Olga V. Pankova, Liubov A. Tashireva, Evgeny O. Rodionov, Sergey V. Miller, Sergey A. Tuzikov, Dmitry S. Pismenny, Tatiana S. Gerashchenko, Marina V. Zavyalova, Sergey V. Vtorushin, Evgeny V. Denisov, Vladimir M. Perelmuter
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant
Externí odkaz:
https://doaj.org/article/7bcc58c5dc8941979d70eb6dca5b594f
Autor:
Matvey M. Tsyganov, Evgeny O. Rodionov, Marina K. Ibragimova, Sergey V. Miller, Olga V. Cheremisina, Irina G. Frolova, Sergey A. Tuzikov, Nikolai V. Litviakov
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 10; Pages: 1647
Objectives: A growing body of evidence suggests the important role of chemosensitive gene expression in the prognosis of patients with lung cancer. However, studies on combined gene expression assessments for personalized prescriptions of chemotherap
Autor:
Yuri S. Vinnik, Nadezhda M. Markelova, Sergey V. Miller, Ekaterina S. Vasilyenya, Elena S. Cherepanova, Andrey V. Yakovlev, Elena V. Repina, Andrey A. Shageev, Ekaterina I. Shishatskaya
Publikováno v:
Журнал Сибирского федерального университета: Серия Биология, Vol 5, Iss 4, Pp 387-403 (2012)
The paper reports analysis of results of the first limited clinical trials of high technology medical devices prepared using polyhydroxyalkanoates (PHAs) – degradable microbial biopolymers: PHA coated mesh stents for surgical repair of inguinal her
Externí odkaz:
https://doaj.org/article/0cfc895d9a494bc5a04eaa7ef2428d2a
Autor:
Evgeny V. Denisov, Sergey V. Vtorushin, Olga V. Pankova, Tatiana S. Gerashchenko, Vladimir M. Perelmuter, Sergey V. Miller, Sergey A. Tuzikov, Liubov A. Tashireva, Dmitry S. Pismenny, E.O. Rodionov, M.V. Zavyalova
Publikováno v:
Frontiers in Oncology
Frontiers in oncology. 2021. Vol. 11. P. 771802 (1-10)
Frontiers in Oncology, Vol 11 (2021)
Frontiers in oncology. 2021. Vol. 11. P. 771802 (1-10)
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant
Autor:
Nikolay Litvyakov, Nadezhda V. Cherdyntseva, Matvey M. Tsyganov, Irina Frolova, Yevgeniy Rodionov, Sergey A. Tuzikov, Svetlana Velichko, Sergey V. Miller, Leonid Yefteev, A. V. Goldberg, Yevgeniy Yumov
Publikováno v:
Problems in oncology. 65:393-398
We analyzed the results of treatment of 68 patients with NSCLC stage III, of which the main group included 36 patients with perioperative chemotherapy vinorelbin / carboplatin. The control group included 32 patients who underwent only surgical treatm
Autor:
I.V. Deryusheva, Sergey A. Tuzikov, Nikolay Litvyakov, Vitaliy Aleksandrovich Markovich, E.O. Rodionov, Matvey M. Tsyganov, Sergey V. Miller, Umidzhon Butabekovich Urmonov, Leonid Aleksandrovich Efteev
Publikováno v:
AVICENNA BULLETIN. 21:420-425
Objective: To study the long-term results of the combined treatment of non-small cell lung cancer (NSCLC) using pre-surgery chemotherapy, radical surgery and personalized adjuvant chemotherapy based on the level of monoresistance genes. Methods: Four
Autor:
Matvey, M Tsyganov, Evgeny, O Rodionov, Alina, M Pevzner, Marina, K Ibragimova, Sergey, V Miller, Olga, V Cheremisina, Irina, G Frolova, Sergey, A Tuzikov, Nikolai, V Litviakov
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(4)
Currently, more researchers are attracted by the possibility of assessing the sensitivity of a lung tumor to certain chemotherapy drugs and their personalized choice based on an assessment of this sensitivity. The purpose of this study was to explore
Autor:
Sergey A. Tuzikov, Sergey V. Miller, Evgeny V. Denisov, Vladimir M. Perelmuter, Tatiana S. Gerashchenko, Olga V. Pankova, E.O. Rodionov, Liubov A. Tashireva
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Basal cell hyperplasia (BCH) and squamous metaplasia (SM) in the small bronchi distant from the tumor is associated with a high risk of non-small cell lung cancer (NSCLC) recurrence. Here, we assessed whether neoadjuvant chemotherapy (NAC
Autor:
Tuzikov Sa, Lyubov Pisareva, I.V. Deryusheva, Nadezhda V. Cherdyntseva, M.K. Ibragimova, Matvey M. Tsyganov, Nikolay Litvyakov, Yevgeniy Rodionov, Sergey V. Miller, Yuliya Kzhyshkovska
Publikováno v:
Problems in oncology. 63:122-127
A significant role in the development of lung tumor resistance to drug therapy play so called mono resistance genes that determine resistance/sensitivity of tumor cells to distinct chemotherapeutic agents, they include BRCA1, RRM1, ERCC1, TOP1, TOP2a